Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB-0998 Desensitization for Kidney Transplant
NCT02032095Phase 3Completed
- Sponsor
- Japan Blood Products Organization
- Start
- Nov 2013
- Primary completion
- Sep 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin in end stage renal disease (ESRD), sponsored by Japan Blood Products Organization. Started Nov 2013; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02032095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032095.